Health Insurance Innovations, Inc. (NASDAQ:HIIQ) has received a consensus recommendation of “Buy” from the eight analysts that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $25.20.

HIIQ has been the topic of a number of research analyst reports. TheStreet raised shares of Health Insurance Innovations from a “c” rating to a “b-” rating in a research note on Monday, May 22nd. Zacks Investment Research raised shares of Health Insurance Innovations from a “hold” rating to a “buy” rating and set a $26.00 price target on the stock in a research note on Friday, June 2nd. Craig Hallum initiated coverage on shares of Health Insurance Innovations in a research note on Monday, June 12th. They issued a “buy” rating and a $28.00 price target on the stock. Canaccord Genuity initiated coverage on shares of Health Insurance Innovations in a research note on Monday, March 13th. They issued a “buy” rating and a $28.00 price target on the stock. Finally, Raymond James Financial, Inc. raised shares of Health Insurance Innovations from a “market perform” rating to an “outperform” rating and set a $20.00 price target on the stock in a research note on Thursday, May 4th.

Health Insurance Innovations (NASDAQ:HIIQ) traded down 4.83% during mid-day trading on Monday, reaching $23.65. 196,468 shares of the company were exchanged. The company has a 50 day moving average of $20.83 and a 200-day moving average of $17.76. Health Insurance Innovations has a 1-year low of $3.73 and a 1-year high of $25.25. The company has a market capitalization of $279.47 million, a price-to-earnings ratio of 21.34 and a beta of 0.65.

Health Insurance Innovations (NASDAQ:HIIQ) last released its quarterly earnings results on Wednesday, May 3rd. The financial services provider reported $0.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05. The business had revenue of $55.87 million for the quarter, compared to the consensus estimate of $54.18 million. Health Insurance Innovations had a net margin of 4.77% and a return on equity of 20.05%. On average, equities research analysts forecast that Health Insurance Innovations will post $1.44 EPS for the current year.

TRADEMARK VIOLATION WARNING: This article was first reported by American Banking News and is the property of of American Banking News. If you are viewing this article on another site, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/06/19/health-insurance-innovations-inc-hiiq-given-consensus-rating-of-buy-by-brokerages-2.html.

In related news, CFO Michael D. Hershberger sold 5,000 shares of the company’s stock in a transaction that occurred on Monday, April 3rd. The shares were sold at an average price of $15.94, for a total transaction of $79,700.00. Following the sale, the chief financial officer now directly owns 113,369 shares of the company’s stock, valued at approximately $1,807,101.86. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Sheldon Wang sold 24,750 shares of the company’s stock in a transaction that occurred on Friday, May 5th. The stock was sold at an average price of $19.73, for a total transaction of $488,317.50. Following the sale, the insider now directly owns 236,001 shares in the company, valued at $4,656,299.73. The disclosure for this sale can be found here. Insiders sold a total of 148,391 shares of company stock worth $2,847,153 over the last three months. Insiders own 30.00% of the company’s stock.

A number of large investors have recently made changes to their positions in the company. Goldman Sachs Group Inc. increased its stake in shares of Health Insurance Innovations by 96.0% in the first quarter. Goldman Sachs Group Inc. now owns 77,001 shares of the financial services provider’s stock valued at $1,232,000 after buying an additional 37,711 shares during the last quarter. Lyon Street Capital LLC acquired a new stake in shares of Health Insurance Innovations during the first quarter valued at $8,772,000. Tudor Investment Corp ET AL acquired a new stake in shares of Health Insurance Innovations during the first quarter valued at $648,000. Summit Partners Public Asset Management LLC acquired a new stake in shares of Health Insurance Innovations during the first quarter valued at $4,320,000. Finally, Symmetry Peak Management LLC acquired a new stake in shares of Health Insurance Innovations during the first quarter valued at $504,000. 70.48% of the stock is currently owned by hedge funds and other institutional investors.

Health Insurance Innovations Company Profile

Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.

Receive News & Ratings for Health Insurance Innovations Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations Inc. and related companies with MarketBeat.com's FREE daily email newsletter.